TOBREX OPH OINT Rx
Generic Name and Formulations:
Tobramycin 0.3%; contains chlorobutanol.
Alcon Laboratories, Inc.
Indications for TOBREX OPH OINT:
Susceptible infections of conjunctiva and cornea.
Adults and Children:
Severe infections: initially 2 drops every hr or ½ inch of ointment every 3–4 hrs; then may prolong dosing interval. Mild to moderate infections: 1–2 drops every 4 hrs or ½ inch of ointment 2–3 times daily.
Remove contact lenses before using. Pregnancy (Cat.B). Nursing mothers: not recommended.
Concomitant systemic aminoglycosides: monitor levels.
Superinfection, itching, swelling, erythema, sensitivity (discontinue if occurs); oint: may retard corneal healing.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders
- Mortality Rates for Substance Use Disorders, Intentional Injuries Vary Widely By Country
- Facial Emotion Recognition Differentiates Behavioral Variant Frontotemporal Dementia From MDD
- The Challenge of Helping Uninsured Patients While Protecting Practice Finances
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed